Silverberg Bernstein Capital Management LLC Chroma Dex Corp. Transaction History
Silverberg Bernstein Capital Management LLC
- $146 Billion
- Q2 2025
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 99,476 shares of CDXC stock, worth $610,782. This represents 0.98% of its overall portfolio holdings.
Number of Shares
99,476
Previous 95,537
4.12%
Holding current value
$610,782
Previous $659 Million
117.45%
% of portfolio
0.98%
Previous 0.61%
Shares
6 transactions
Others Institutions Holding CDXC
# of Institutions
150Shares Held
24.4MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$7.24 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...